Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions

Brain

Volumn 131, Issue 5, 2008, Pages 1282-1293

  Mackenzie, Ian R A ^a,c   Foti, Dean ^a   Woulfe, John ^b   Hurwitz, Trevor A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Frontotemporal dementia; Frontotemporal lobar degeneration; FTLD U; TDP 43; Ubiquitin

Indexed keywords

ALPHA SYNUCLEIN; DNA BINDING PROTEIN; TAR DNA BINDING PROTEIN 43; UBIQUITIN; UNCLASSIFIED DRUG; PROTEIN TDP 43; PROTEIN TDP-43;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; APHASIA; ARTICLE; BEHAVIOR DISORDER; BRAIN DEGENERATION; CELL INCLUSION; CLINICAL FEATURE; DENTATE GYRUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; GRANULE CELL; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; PHENOTYPE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; UBIQUITINATION; BRAIN; CHEMISTRY; DEMENTIA; MENTAL DISEASE; METABOLISM; NERVE CELL; ONSET AGE; PATHOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; AGE OF ONSET; BRAIN; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; HUMANS; INCLUSION BODIES; MALE; MENTAL DISORDERS; NEURONS; UBIQUITIN;

EID: 44949162153     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn061     Document Type: Article

References (57)

1. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007; 61: 435-45.
2. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-11.
3. Bigio EH, Lipton AM, White CL, Dickson DW, Hirano A. Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 2003; 29: 239-53.
4. Bird T, Knopman D, Van Swieten J, Rosso S, Feldman H, Tanabe H, et al. Epidemiology and genetics of frontotemporal dementia/Pick's disease. Ann Neurol 2003; 54 (Suppl 5): S29-31.
5. Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE. Nuclear factor TDP-43 and SP proteins promote in vitro and in vivo CFTR exon skipping. EMBO J 2001; 20: 1774-84.
6. Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007a; 114: 5-22.
7. Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, et al. Clinical and neuropathological variation in neuronal intermediate filament inclusion disease. Neurology 2004; 26: 1376-84.
8. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 2007b; 171: 227-40.
9. Chow TW, Miller BL, Hayashi VN, Geschwind DH. Inheritance of frontotemporal dementia. Arch Neurol 1999; 56: 817-22.
10. Davidson Y, Kelley T, Mackenzie IRA, Pickering-Brown S, Du Plessis D, Neary D, et al. Neary Ubiquitinated pathological, lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 2007; 113: 521-33.
11. Feldman H, Levy AR, Hsiung GY, Peters KR, Donald A, Black SE, et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 2003; 22: 265-74.
12. Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuopathol Exp Neurol 2006; 65: 571-81.
13. Forman MS, Trojanowski JQ, Lee VMY. TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol 2007; 17: 548-55.
14. Freeman SH, Spires-Jones T, Hyman BT, Growdon JH, Frosch MP. TAR-DNA binding protein 43 in Pick disease. J Neuropathol Exp Neurol 2008; 67: 62-7.
15. Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, Igaz LM, et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 2008; 115: 133-45.
16. Gydesen S, Brown JM, Brun A, Chakrabarti L, Gade A, Johannsen P, et al. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 2002; 59: 1585-94.
17. Hamada K, Fukazawa T, Yanagihara T, Yoshida K, Hamada T, Yoshimura N, et al. Dementia with ALS features and diffuse Pick body-like inclusions (atypical Pick's disease?). Clin Neuropathol 1995; 14: 1-6.
18. Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, et al. Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 2007; 1184: 284-94.
19. Holm IE, Englund E, Mackenzie IRA, Johannsen P, Isaacs A. A Reassessment of the Neuropathology of Frontotemporal Dementia Linked to Chromosome 3 (FTD-3). J Neuropathol Exp Neurol 2007; 66: 884-91.
20. Ishihara K, Araki S, Ihori N, Shiota JI, Kawamura M, Nakano I. An autopsy case of frontotemporal dementia with sever dysarthria and motor neuron disease showing numerous basophilic inclusions. Neuropathology 2006; 26: 447-54.
21. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996; 5: 339-50.
22. Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, et al. Frontotemporal lobar degeneration. Demographic characteristics of 353 patients. Arch Neurol 2005; 62: 925-30.
23. Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003; 126: 2291-303.
24. Jospehs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004; 30: 369-73.
25. Katsuse O, Dickson DW. Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease. Alz Dis Assoc Disord 2005; 19 (Suppl 1): S37-43.
26. Kusaka H, Matsumoto S, Imai T. Adult-onset motor neuron disease with basophilic intraneuronal inclusion bodies. Clin Neuropathol 1993; 12: 215-8.
27. Kwong LK, Neumann M, Sampathu DM, Lee VMY, Trojanowski JQ. TDP-43 proteinopathy: a neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Act Neuropathol 2007; 114: 63-70.
28. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002; 59: 1077-9.
29. The Lund & Manchester Groups. Consensus statement. Clinical and neuropathological criteria for fronto-temporal dementia. J Neurosurg Neurol Psychiatry 1994; 4: 416-8.
30. Mackenzie IRA, Baborie A, Pickering-Brown S, du Pleissis D, Jaros E, Perry RH, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 2006a; 112: 539-49.
31. Mackenzie IRA, Baker M, Pickering-Brown S, Hsiung GYR, Lindholm C, Dwosh E, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 2006b; 129: 3081-90.
32. Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic ALS from ALS with SOD-1 mutations. Ann Neurol 2007; 61: 427-34.
33. Mackenzie IR, Feldman H. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol 2004; 23: 183-93.
34. Mackenzie IRA, Shi J, Shaw CL, DuPlessis D, Neary D, Snowden JS, et al. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol 2006c; 112: 539-49.
35. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological criteria for fronto-temporal dementia. Arch Neurol 2001; 58: 1803-9.
36. Mercado PA, Ayala YM, Romano M, Buratti E, Baralle FE. Depletion of TDP43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 2005; 33: 6000-10.
37. Mosaheb S, Thorpe JR, Hashemzadeh-Bonehi L, Bigio EH, Gearing M, Cairns NJ. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease. Acta Neuropathol 2005; 110: 360-8.
38. Munoz-Garcia D, Ludwin SK. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study. Ann Neurol 1984; 16: 467-80.
39. Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 2007; 114: 221-9.
40. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
41. Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VMY. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 2007a; 64: 1388-94.
42. Neumann M, Kwong LK, Traux AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin, et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol 2007b; 66: 177-83.
43. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-3.
44. Okamoto K, Murakami N, Kusaka H, Yoshida M, Hashizume Y, Nakazato Y, et al. Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol 1992; 239: 426-30.
45. Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Anderson PM, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006; 67: 1074-7.
46. Probst A, Taylor KI, Tolnay M. Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 2007; 114: 335-45.
47. Rademakers R, Hutton M. The genetics of frontotemporal lobar degeneration. Curr Neurol Neurosci Rep 2007; 7: 434-42.
48. Rosso SM, Donker KL, Baks T, Joosse M, de Koning I, Pijnenburg Y, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003; 126: 2016-22.
49. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006; 169: 1343-52.
50. Sanelli T, Xiao S, Horne P, Bilbao J, Zinman L, Robertson J. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2007; 66: 1147-53.
51. Stevens M, van Duijn CM, Kamphorst W, de Knijff P, Heutink P, van Gool WA, et al. Familial aggregation in frontotemporal dementia. Neurology 1998; 50: 1541-5.
52. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, et al. TDP-43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 2007; 35: 320-7.
53. Trojanowski JQ, Dickson D. Update on the neuropathological diagnosis of frontotemporal dementia. J Neuropathol Exp Neurol 2001; 60: 1123-6.
54. Tsuchiya K, Matsunaga T, Aoki M, Haga C, Ooe K, Abe K, et al. Familial amyotrophic lateral sclerosis with posterior column degeneration and basophilic inclusion bodies: a clinical, genetic and pathological study. Clin Neuropathol 2001; 20: 53-9.
55. Wightman G, Anderson VER, Martin J, Swash M, Anderton BH, Neary D, et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 1992; 139: 269-74.
56. Woulfe JM. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress. Neuopathol Appl Neurobiol 2007; 33: 2-42.
57. Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, et al. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol (in press).